Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
43
PDSB Quote, Financials, Valuation and Earnings
Last price:
$1.65
Seasonality move
:
10.18%
Day range:
$1.53 - $1.68
52-week range:
$0.85 - $4.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.13x
Volume:
771K
Avg. volume:
585.2K
1-year change:
-47.33%
Market cap:
$69.9M
Revenue:
--
EPS (TTM):
-$0.94
PDS Biotechnology Number of Institutional Trades
PDS Biotechnology Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$22.7M
(Last 6 Months)
Current Institutional Ownership Percentage
22.7%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$46.6M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PDS Biotechnology Institutional Ownership
-
What Percentage Of PDSB Is Owned by Institutions?
22.7% of PDSB is owned by institutions.
-
How Many Institutions Own PDSB Shares?
PDS Biotechnology stock is owned by 134 institutional shareholders at this time.
-
Have Institutions Been Buying PDSB Stock?
Yes, institutions have bought 15.5M shares of PDSB in the last quarter.
-
Have Institutions Been Selling PDSB Stock?
Yes, institutions have sold 14.6M shares of PDSB over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 5
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
